Cover Image
市場調查報告書

遺傳性地中海熱:全球臨床實驗檢討

Familial Mediterranean Fever Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 318346
出版日期 內容資訊 英文 75 Pages
訂單完成後即時交付
價格
Back to Top
遺傳性地中海熱:全球臨床實驗檢討 Familial Mediterranean Fever Global Clinical Trials Review, H2, 2014
出版日期: 2014年10月31日 內容資訊: 英文 75 Pages
簡介

本報告提供遺傳性地中海環境熱能的臨床試驗相關的基本資料和數據,為您彙整實驗數量及受驗者的募集情況,各階段趨勢,臨床試驗的主要製藥企業及研究機關簡介等資料。

簡介

  • 遺傳性地中海環境熱能
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 歐洲主要5個國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量

G7各國臨床實驗數量:遺傳性地中海熱免疫疾病治療藥臨床實驗上的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:遺傳性地中海熱免疫疾病治療藥臨床實驗上的比例

E7各國的各階段臨床實驗數量

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

遺傳性地中海熱治療藥臨床實驗的主要參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Sun Pharmaceutical Industries Limited
    • Novartis AG
    • Bellus Health Inc.
  • 有代表性的研究機關·醫院臨床實驗概要
    • The Sheba Medical Center
    • National Institute of Arthritis and Musculoskeletal and Skin Diseases
    • The Cleveland Clinic
    • Rambam Health Care Campus

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2396CTIDB

GlobalData's clinical trial report, "Familial Mediterranean Fever Global Clinical Trials Review, H2, 2014" provides data on the Familial Mediterranean Fever clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Familial Mediterranean Fever. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Familial Mediterranean Fever. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Familial Mediterranean Fever
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Familial Mediterranean Fever to Immunology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Familial Mediterranean Fever to Immunology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Familial Mediterranean Fever
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Familial Mediterranean Fever Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
  • Clinical Trial Overview of Top Companies
    • Sun Pharmaceutical Industries Limited
      • Clinical Trial Overview of Sun Pharmaceutical Industries Limited
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Bellus Health Inc.
      • Clinical Trial Overview of Bellus Health Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • The Sheba Medical Center
      • Clinical Trial Overview of The Sheba Medical Center
      • National Institute of Arthritis and Musculoskeletal and Skin Diseases
      • Clinical Trial Overview of National Institute of Arthritis and Musculoskeletal and Skin Diseases
      • The Cleveland Clinic
      • Clinical Trial Overview of The Cleveland Clinic
      • Rambam Health Care Campus
      • Clinical Trial Overview of Rambam Health Care Campus
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Familial Mediterranean Fever Therapeutics, Global, Clinical Trials by Region, 2014*
  • Familial Mediterranean Fever Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Familial Mediterranean Fever Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Familial Mediterranean Fever Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Familial Mediterranean Fever Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Familial Mediterranean Fever Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Proportion of Familial Mediterranean Fever to Immunology Clinical Trials, G7 Countries (%), 2014*
  • Familial Mediterranean Fever Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Familial Mediterranean Fever Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Familial Mediterranean Fever to Immunology Clinical Trials, E7 Countries (%), 2014*
  • Familial Mediterranean Fever Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Familial Mediterranean Fever Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Familial Mediterranean Fever Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Familial Mediterranean Fever Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Familial Mediterranean Fever Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Familial Mediterranean Fever Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Familial Mediterranean Fever Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Familial Mediterranean Fever Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Familial Mediterranean Fever Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Familial Mediterranean Fever Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Familial Mediterranean Fever Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Familial Mediterranean Fever Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Pharmaceutical Industries Limited, 2014*
  • Familial Mediterranean Fever Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Familial Mediterranean Fever Therapeutics Clinical Trials Market, Global, Clinical Trials by Bellus Health Inc., 2014*
  • Familial Mediterranean Fever Therapeutics Clinical Trials Market, Global, Clinical Trials by The Sheba Medical Center, 2014*
  • Familial Mediterranean Fever Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Arthritis and Musculoskeletal and Skin Diseases, 2014*
  • Familial Mediterranean Fever Therapeutics Clinical Trials Market, Global, Clinical Trials by The Cleveland Clinic, 2014*
  • Familial Mediterranean Fever Therapeutics Clinical Trials Market, Global, Clinical Trials by Rambam Health Care Campus, 2014*

List of Figures

  • Familial Mediterranean Fever Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Familial Mediterranean Fever Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Familial Mediterranean Fever Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Familial Mediterranean Fever Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Proportion of Familial Mediterranean Fever to Immunology Clinical Trials, G7 Countries (%), 2014*
  • Familial Mediterranean Fever Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Familial Mediterranean Fever Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Familial Mediterranean Fever to Immunology Clinical Trials, E7 Countries (%), 2014*
  • Familial Mediterranean Fever Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Familial Mediterranean Fever Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Familial Mediterranean Fever Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Familial Mediterranean Fever Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Familial Mediterranean Fever Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Familial Mediterranean Fever Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Familial Mediterranean Fever Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Familial Mediterranean Fever Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Familial Mediterranean Fever Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Familial Mediterranean Fever Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top